Home / Lopinavir and Ritonavir / United States
US ATC J05AR10 · updated 2 Nov 2026
Lopinavir and Ritonavir shortage in United States
Is there a Lopinavir and Ritonavir shortage in United States?
Yes. As of 2 Nov 2026, 5 Lopinavir and Ritonavir products are reported short in United States, the first since 24 Jul 2026. No return date has been given. Main reason: not stated.
Also short in Canada, Italy. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Kaletra, Oral Solution, 80 mg/1 mL; 20 mg/1 mL (NDC 0074-3956-46) discontinuation | AbbVie Inc. | 24 Jul 2026 | not given | Not stated |
| US | Kaletra, Tablet, 100 mg; 25 mg (NDC 0074-3008-60) discontinuation | AbbVie Inc. | 24 Jul 2026 | not given | Not stated |
| US | Kaletra, Tablet, 200 mg; 50 mg (NDC 0074-4014-12) discontinuation | AbbVie Inc. | 24 Jul 2026 | not given | Not stated |
| US | Kaletra, Tablet, 100 mg; 25 mg (NDC 0074-0522-60) discontinuation | AbbVie Inc. | 24 Jul 2026 | not given | Not stated |
| US | Kaletra, Tablet, 200 mg; 50 mg (NDC 0074-6799-22) discontinuation | AbbVie Inc. | 24 Jul 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).